Literature DB >> 7327961

Pulmonary vascular tone improves VA/Q matching in obliterative pulmonary hypertension.

D R Dantzker, J S Bower.   

Abstract

We have studied the influence of pulmonary vascular tone on ventilation-perfusion relationships in subjects with chronic obliterative pulmonary vascular disease. We administered oxygen, isoproterenol, or nitroprusside on 15 occasions in 7 subjects and observed a fall in pulmonary vascular resistance of greater than 15% in 8 of these 15 trials. When pulmonary vascular resistance was reduced, there was an increase in the perfusion of lung units with low ventilation-perfusion ratios (VA/Q) and/or shunt as determined by the multiple inert gas technique. The pattern of increased VA/Q inequality was independent of the specific agent used. In only one instance in which pulmonary vascular resistance was not reduced did drug administration lead to a worsening of VA/Q relationships. The detrimental effect of the increased perfusion of low VA/Q units on arterial oxygenation was frequently attenuated by an increased mixed venous oxygen content due to an increase in total cardiac output. We conclude that pulmonary vascular tone contributes to the maintenance of VA/Q matching in subjects with obstruction of the pulmonary vascular bed.

Entities:  

Mesh:

Year:  1981        PMID: 7327961     DOI: 10.1152/jappl.1981.51.3.607

Source DB:  PubMed          Journal:  J Appl Physiol Respir Environ Exerc Physiol        ISSN: 0161-7567


  8 in total

1.  The hepatopulmonary syndrome: new name, old complexities.

Authors:  R Rodríguez-Roisin; A G Agustí; J Roca
Journal:  Thorax       Date:  1992-11       Impact factor: 9.139

2.  Pulmonary hypertension.

Authors:  T Higenbottam; J Wallwork
Journal:  Br Med J (Clin Res Ed)       Date:  1987-03-14

Review 3.  Contribution of multiple inert gas elimination technique to pulmonary medicine--4. Gas exchange abnormalities in pulmonary vascular and cardiac disease.

Authors:  G Manier; Y Castaing
Journal:  Thorax       Date:  1994-11       Impact factor: 9.139

4.  Prediction of favourable responses to long term vasodilator treatment of pulmonary hypertension by short term administration of epoprostenol (prostacyclin) or nifedipine.

Authors:  A Rozkovec; J R Stradling; G Shepherd; J MacDermot; C M Oakley; C T Dollery
Journal:  Br Heart J       Date:  1988-06

Review 5.  Gas exchange and pulmonary hypertension following acute pulmonary thromboembolism: has the emperor got some new clothes yet?

Authors:  John Y C Tsang; James C Hogg
Journal:  Pulm Circ       Date:  2014-06       Impact factor: 3.017

6.  Reduction of pulmonary capillary blood volume in patients with severe unexplained pulmonary hypertension.

Authors:  C Borland; Y Cox; T Higenbottam
Journal:  Thorax       Date:  1996-08       Impact factor: 9.139

7.  Estimation of endothelin-mediated vasoconstriction in acute pulmonary thromboembolism.

Authors:  John Y C Tsang; Wayne J E Lamm
Journal:  Pulm Circ       Date:  2012 Jan-Mar       Impact factor: 3.017

8.  Chronic hypoxia aggravates monocrotaline-induced pulmonary arterial hypertension: a rodent relevant model to the human severe form of the disease.

Authors:  Florence Coste; Christelle Guibert; Julie Magat; Emma Abell; Fanny Vaillant; Mathilde Dubois; Arnaud Courtois; Philippe Diolez; Bruno Quesson; Roger Marthan; Jean-Pierre Savineau; Bernard Muller; Véronique Freund-Michel
Journal:  Respir Res       Date:  2017-03-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.